Purple Biotech Ltd ADR (PPBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -5,252 | -2,628 | N/A | N/A |
| Accounts receivable | -375 | -110 | N/A | N/A |
| Accounts payable and accrued liabilities | 453 | -11 | N/A | N/A |
| Other Working Capital | -130 | 134 | N/A | N/A |
| Other Operating Activity | 778 | 2,103 | 0 | 0 |
| Operating Cash Flow | $-4,526 | $-512 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | -114 | 686 | N/A | N/A |
| Debt Repayment | -722 | N/A | N/A | N/A |
| Common Stock Issued | 7,254 | 27 | N/A | N/A |
| Other Financing Activity | -596 | -12 | 0 | 0 |
| Financing Cash Flow | $5,822 | $701 | $N/A | $N/A |
| Exchange Rate Effect | -176 | 4 | N/A | N/A |
| Beginning Cash Position | 193 | N/A | N/A | N/A |
| End Cash Position | 1,313 | 193 | N/A | N/A |
| Net Cash Flow | $1,120 | $193 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,526 | -512 | N/A | N/A |
| Free Cash Flow | -4,526 | -512 | 0 | 0 |